The global medical device testing services market is estimated to surge at a CAGR of 6.59% from a market value of USD9.551 billion in 2019 to achieve a market value of USD14.007 billion by the end of 2025. Medical device testing services are the most commonly utilized testing services and solutions that are performed within the medical industry. Hence with the growing medical device industry at the global level, the market is projected to hold strong growth prospects during the forecast period. The growing prevalence of chronic diseases requiring state-of-the-art medical devices for testing and treatment purposes is further augmenting the market demand during the course of the forecast period. The presence of companies offering varied medical device testing services is further contributing to fueling the market growth in the forecast period. For example, companies offer medical device testing services for biocompatibility testing, biological safety, chemical characterization, and analytical chemistry, environmental monitoring, long-term and accelerated shelf-life testing among others. Furthermore, with the growing need for testing the quality and reliability of medical devices, the market for medical device testing services holds strong growth opportunities during the forecast period.
Medical device testing services are also offered by companies that provide full support right from the device concept designing to post-market applications. These services are highly beneficial owing to the presence of stringent regulations for product development, hence, any defect in a medical device or inability of a medical device to serve the required medical purpose would lead to product disqualification. Therefore, the presence of strict regulations for device development and approval is contributing to surging market demand during the forecast period. For example, NAMSA, a medical organization, based out of Toledo, Ohio, United States helps in speeding product development for medical devices, In-Vitro Diagnostics, regenerative medicine, and combination products. By utilizing its MRO® approach, the company plays a significant role in translational research, and through the application of its unique combination of solutions that include medical device testing, regulatory, reimbursement, and quality consulting, and clinical research services, the company offers support throughout the full development continuum, from bench to actual patient applications. The company’s offices are located across the Asian, European, and North American regions and support fast-track market introduction in the major markets of the world.
Geographically, North America is projected to hold a significant market share, while the Asia Pacific region is estimated to be the fastest-growing market in the global medical device testing services market during the forecast period.
COVID-19 impact on the medical device testing services market: It has been noticed at the global level that the novel coronavirus pandemic has severely affected medical device manufacturing. This is mainly due to the fact that medical device manufacturers are dependent on healthcare facilities for their clinical trial data collection. It is required that almost every medical device must pass through different stages of clinical trials that include pre-market and post-market studies before the medical device certification for market approval. As the COVID-19 pandemic continues to increase, medical device companies are facing difficulties in order to make informed decisions regarding their products, supply chain, and regulatory obligations. Hence, the market at present is projected to be impacted in the current year in comparison to the previous years amid the novel coronavirus pandemic scenario.
The growing medical device industry will continue to surge the market demand during the forecast period along with the emergence of novel and innovative medical devices.
The global medical device industry is projected to grow at a steady pace during the forecast period. The industrial growth is further supported by the growing demand for innovative medical devices which include wearables, and innovative health services like health data. This is mainly due to the fact that lifestyle diseases are gaining momentum with time due to the adoption of unhealthy living conditions, hence, this is creating a high demand for the development of portable medical devices in order to keep a constant check on the vital parameters, further providing robust market growth prospects during the forecast period. The governments around the globe are working on cutting healthcare costs (especially on lowering the number of hospital visits) and demand greater value regarding improved patient outcomes. To achieve this, companies are expected to step out of their traditional device manufacturing. Instead, a need for the integration of services and data intelligence coupled with their products is being realized in order to deliver holistic solutions, further bolstering the B2B activities and strengthening the creation of the new business-to-consumer (B2C) activities. This will further require the manufacturers to adopt different strategies in the form of mergers & acquisitions, and strategic partnerships and collaborations. The medical device companies will ultimately be involved in playing a bigger role in the value chain and would get an opportunity to closely interact with the end consumers. This would further aid in increasing the company revenues and in turn, would definitely contribute to lowering the number of hospital visits.
Additionally, with medical devices having a direct impact on human lives, it is necessary that these devices deliver safe and effective healthcare services to patients. To achieve this, it is expected that all the medical device manufacturers follow the proper medical device testing procedures which include verification, and validation practices, and ensure that the quality and reliability of medical devices are maintained in accordance with the required medical need.
By utilizing the various medical device testing strategies, it is expected out of a medical device manufacturer that the company checks each and every functionality of its medical device right from the concept designing stage to the post-market applications. In the case of any defect found, it would lead to huge losses to the company. Hence, with the growing medical device industry, medical device testing services hold importance in order to assist in the proper manufacturing of the device. Testing service can be provided in-house or can be outsourced. Furthermore, with the surging number of chronic diseases worldwide, the market is projected to hold strong growth prospects along with the development of novel medical devices through continuous innovations and technological advancements.
|Market size value in 2019||US$9.551 billion|
|Market size value in 2025||US$14.007 billion|
|Growth Rate||CAGR of 6.59% from 2019 to 2025|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Type, Services, Sourcing Type, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||SGS SA, Intertek Group plc, Bureau Veritas, DEKRA, TÜV SÜD, Eurofins Scientific, The British Standards Institution, Nelson Laboratories, LLC (A Sotera Health Company)|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Intertek Group plc
The British Standards Institution
Nelson Laboratories, LLC (A Sotera Health Company)
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.